MS drug linked to virus
BIDMC researchers have found the virus responsible for PML (progressive multifocal leukoencephalopathy) can be reactivated in multiple sclerosis patients being treated with natalizumab (Tysabri).
The findings appear in today's issue of The New England Journal of Medicine (NEJM)
PML is a rare brain disease that typically affects AIDS patients and other individuals with compromised immune systems.
For more on the study, click here. For a look at some coverage, click here.